<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2341-4545</journal-id>
<journal-title><![CDATA[GE-Portuguese Journal of Gastroenterology]]></journal-title>
<abbrev-journal-title><![CDATA[GE Port J Gastroenterol]]></abbrev-journal-title>
<issn>2341-4545</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Gastrenterologia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2341-45452025000300035</article-id>
<article-id pub-id-type="doi">10.1159/000541219</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Validation of the Portuguese Version of IBD-Control Questionnaire and Comparison with IBD-Disk]]></article-title>
<article-title xml:lang="pt"><![CDATA[Validação da versão portuguesa do questionário IBD-Control e comparação com o IBD-Disk]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[Tânia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Franco]]></surname>
<given-names><![CDATA[Joana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guimarães]]></surname>
<given-names><![CDATA[Andreia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[José Damasceno]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mendes]]></surname>
<given-names><![CDATA[So&#64257;a]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Leal]]></surname>
<given-names><![CDATA[Tiago]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rebelo]]></surname>
<given-names><![CDATA[Ana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arroja]]></surname>
<given-names><![CDATA[Bruno]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gonçalves]]></surname>
<given-names><![CDATA[Raquel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Soares]]></surname>
<given-names><![CDATA[João Bruno]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Unidade Local de Saúde de Braga Gastroenterology Department ]]></institution>
<addr-line><![CDATA[Braga ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,University of Minho School of Medicine ]]></institution>
<addr-line><![CDATA[Braga ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<volume>32</volume>
<numero>3</numero>
<fpage>35</fpage>
<lpage>46</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2341-45452025000300035&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2341-45452025000300035&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2341-45452025000300035&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  The IBD-Control questionnaire and IBD-Disk are two patient-reported outcome measures designed to evaluate the impact of in&#64258;ammatory bowel disease (IBD) on different health domains. Unlike IBD-Disk, there is no fully published validated Portuguese version of IBD-Control. Furthermore, the two instruments have not yet been compared. We aimed to translate and validate IBD-Control in Portugal and compare it with IBD-Disk.  Methods:  After translation into Portuguese, the IBD-Control was administered to IBD patients, at baseline (T0), after 1-4 weeks (T1), and &gt;3 months (T2). Patients also completed the Portuguese versions of the PRO2, EQ-5D, SIBDQ, and IBD-Disk. We assessed the reliability, validity, responsiveness, and interpretability of IBD-Control. We compared the usability (3 questions) and the ability to identify good disease control (area under the curve [AUC]) of IBD-Control and IBD-Disk.  Results:  At T0, the IBD-Control was completed by 142 patients (108 Crohn&#8217;s disease, 34 ulcerative colitis). At T1 and T2, 68 and 101 patients completed the questionnaire, respectively. Factor analysis con&#64257;rmed the one-dimensionality of the scale with 8 items (IBD-Control-8). Internal consistency (Cronbach&#8217;s alpha) was 0.80. Test-retest reproducibility for stable patients (n = 54) was high (intraclass correlation coef&#64257;cient-0.86). IBD-Control-8 signi&#64257;cantly correlated (r between 0.55 and 0.82; p &#8804; 0.001) with PRO2, EQ-5D, SIBDQ and IBD-Disk. The variation in IBD-Control-8 between T0 and T2 correlated signi&#64257;cantly (r between 0.48 and 0.53; p &#8804; 0.01) with the variation in PRO2 (only for Crohn&#8217;s disease), SIBDQ and IBD-Disk. The IBD-Control-8 signi&#64257;cantly discriminated between well and poorly controlled disease (15 ± 2 vs.11 ± 4; p &lt; 0.001). No signi&#64257;cant differences were observed between IBD-Control-8 and IBD-Disk regarding usability and the ability to identify good disease control (AUC: &#8722;0.79 vs. 0.76, respectively).  Conclusions:  The IBD-Control is reliable and valid for measuring disease control from the perspective of patients with IBD in Portugal, presenting no signi&#64257;cant differences regarding usability and assessment of disease control when compared to IBD-Disk.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução:  Os questionários IBD-Control e o IBD-Disk são duas medidas de saúde reportada pelos doentes, destinados a medir o impacto da Doença In&#64258;amatória Intestinal (DII) nos diferentes domínios da saúde. Contrariamente ao IBD-Disk, não existe uma versão Portu-guesa do IBD-Control validada e totalmente publicada. Além disso, os dois instrumentos não foram com-parados. Pretendemos traduzir e validar o IBD-Control em Portugal e compará-lo com o IBD-Disk.  Métodos:  Após tradução para Português, o IBD-Control foi administrado a doentes com DII, numa avaliação inicial (T0), após 1-4 semanas (T1) e &gt;3meses (T2). Osdoentes preencheram também as versões portuguesas do PRO2, EQ-5D, SIBDQ e IBD-Disk. Avaliámos a &#64257;abilidade, validade, responsividade e interpretabilidade do IBD-Control. Comparámos a usabilidade (3 perguntas) e a capacidade para identi&#64257;car um bom controlo da doença (análise AUC) do IBD-Control e do IBD-Disk.  Resultados:  Em T0, o IBD-Control foi preenchido por 142 doentes com DII (108 doença de Crohn, 34 colite ulcerosa). Em T1 e T2, 68 e 101 doentes preencheram o questionário, respetivamente. A análise fatorial con&#64257;rmou a unidi-mensionalidade da escala com 8 itens (IBD-Control-8). A consistência interna (alfa de Cronbach) foi de 0,80. A reprodutibilidade teste-reteste para doentes estáveis (n = 54) foi elevada (coe&#64257;ciente de correlação intraclasse-0,86). O IBD-Control-8 correlacionou-se signi&#64257;cativamente (r entre 0,55 e 0,82; p &#8804; 0,001) com o PRO2, EQ-5D, SIBDQ e IBD-Disk. A variação do IBD-Control-8 entre T0 e T2 correlacionou-se signi&#64257;cativamente (r entre 0,48 e 0,53; p &#8804; 0,01) com a variação no PRO2 (apenas para a doença de Crohn), short-IBQ e IBD-Disk. O IBD-Control-8 discriminou sig-ni&#64257;cativamente a doença bem e mal controlada (15 ± 2 vs. 11 ± 4; p &lt; 0,001). Não foram observadas diferenças signi&#64257;cativas entre o IBD-Control e o IBD-Disk relativamente à usabilidade e à capacidade para identi&#64257;cação de doença bem controlada (AUC: &#8722;0,79 vs. 0,76, respetivamente).  Conclusões:  O IBD-Control é &#64257;ável e doente com DII em Portugal, não apresentando diferenças signi&#64257;cativas relativamente à usabilidade e avaliação do controlo da doença quando comparado com o IBD-Disk.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[IBD-Control]]></kwd>
<kwd lng="en"><![CDATA[IBD-Disk]]></kwd>
<kwd lng="en"><![CDATA[In&#64258;ammatory bowel disease]]></kwd>
<kwd lng="en"><![CDATA[Patient-reported outcome measures]]></kwd>
<kwd lng="pt"><![CDATA[IBD-Control]]></kwd>
<kwd lng="pt"><![CDATA[IBD-Disk]]></kwd>
<kwd lng="pt"><![CDATA[Doença in&#64258;amatória intestinal]]></kwd>
<kwd lng="pt"><![CDATA[Medidas de resultado reportados pelos doentes]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seyedian]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Nokhostin]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Malamir]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A review of the diagnosis, prevention, and treatment methods of in?ammatory bowel disease]]></article-title>
<source><![CDATA[J Med Life]]></source>
<year>2019</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>113-22</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chams]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Badran]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sayegh]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Chams]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Shams]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hajj Hussein]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[In?ammatory bowel disease: looking beyond the tract]]></article-title>
<source><![CDATA[Int J Immunopathol Pharmacol]]></source>
<year>2019</year>
<volume>33</volume>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fakhoury]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Negrulj]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mooranian]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Salami]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inflammatory bowel disease: clinical aspects and treatments]]></article-title>
<source><![CDATA[J In?amm Res]]></source>
<year>2014</year>
<volume>7</volume>
<page-range>113-20</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vicente Lidón]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[García López]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Corsino Roche]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Boudet Barraca]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz Segura]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[García Cámara]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Translation into Spanish and validation of a short questionnaire to measure the control of in?ammatory bowel disease from the patient's perspective: IBD-Control, EII-Control]]></article-title>
<source><![CDATA[Gastroenterol Hepatol]]></source>
<year>2022</year>
<volume>45</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>524-34</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernandes]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Gil]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Qualidade de vida da pessoa com doença inflamatória intestinal]]></article-title>
<source><![CDATA[Rev Enf Ref]]></source>
<year>2019</year>
<numero>23</numero>
<issue>23</issue>
<page-range>89-98</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva Mendes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Antunes]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gonçalves]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Leal]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Gonçalves]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the IBD-Disk in a Portuguese cohort]]></article-title>
<source><![CDATA[Eur J Gastroenterol Hepatol]]></source>
<year>2021</year>
<volume>33</volume>
<numero>^s1S Suppl 1</numero>
<issue>^s1S Suppl 1</issue>
<supplement>1S Suppl 1</supplement>
<page-range>e961-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bodger]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ormerod]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Shackcloth]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Harrison]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[IBD Control Collaborative. Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaire]]></article-title>
<source><![CDATA[Gut]]></source>
<year>2014</year>
<volume>63</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1092-102</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Jong]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Taal]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[PWA]]></given-names>
</name>
<name>
<surname><![CDATA[Römkens]]></surname>
<given-names><![CDATA[TEH]]></given-names>
</name>
<name>
<surname><![CDATA[Jansen]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[West]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in in?ammatory bowel disease]]></article-title>
<source><![CDATA[Scand J Gastroenterol]]></source>
<year>2021</year>
<volume>56</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>155-61</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gebeyehu]]></surname>
<given-names><![CDATA[GG]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Dobson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cummings]]></surname>
<given-names><![CDATA[JRF]]></given-names>
</name>
<name>
<surname><![CDATA[Bloom]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: secondary analysis of a nationwide electronic survey]]></article-title>
<source><![CDATA[J Crohns Colitis]]></source>
<year>2024</year>
<volume>18</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>275-85</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Turner]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ricciuto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lewis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[D'Amico]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Dhaliwal]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Grif?ths]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[STRIDE-II: an update on the selecting therapeutic targets in in?ammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>2021</year>
<volume>160</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1570-83</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roseira]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[HT]]></given-names>
</name>
<name>
<surname><![CDATA[Marreiros]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Contente]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Magro]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Short in?ammatory bowel disease questionnaire: translation and validation to the Portuguese language]]></article-title>
<source><![CDATA[Health Qual Life Outcomes]]></source>
<year>2021</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>59</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Irvine]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Short In ammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing in?ammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial]]></article-title>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>1996</year>
<volume>91</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1571-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[Antunes]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[LN]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[LN]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos-Goñi]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set]]></article-title>
<source><![CDATA[Qual Life Res]]></source>
<year>2019</year>
<volume>28</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>3163-75</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghosh]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Louis]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Beaugerie]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bossuyt]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Bouguen]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bourreille]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of the IBD disk: a visual self-administered tool for assessing disability in in?ammatory bowel diseases]]></article-title>
<source><![CDATA[In?amm Bowel Dis]]></source>
<year>2017</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>333-40</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kamper]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ostelo]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Knol]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Maher]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[de Vet]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Hancock]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global Perceived Effect scales provided reliable assessments of health transition in people with musculoskeletal disorders, but ratings are strongly in?uenced by current status]]></article-title>
<source><![CDATA[J Clin Epidemiol]]></source>
<year>2010</year>
<volume>63</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>760-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mokkink]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
<name>
<surname><![CDATA[Terwee]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
<name>
<surname><![CDATA[Patrick]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Stratford]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[Knol]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study]]></article-title>
<source><![CDATA[Qual Life Res]]></source>
<year>2010</year>
<volume>19</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>539-49</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
<name>
<surname><![CDATA[Rosa]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
<name>
<surname><![CDATA[Queirós]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rocha]]></surname>
<given-names><![CDATA[NP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[European Portuguese validation of the system usability scale (SUS)]]></article-title>
<source><![CDATA[Proced Computer Sci]]></source>
<year>2015</year>
<volume>67</volume>
<page-range>293-300</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
